Project description
Integrating China in the International Consortium for Personalised Medicine (IC2PerMed)
Thanks to advances in biomedical and digital technologies, Personalised Medicine (PM) improves healthcare and underpin more efficient and sustainable health systems. In China it is attracting massive interest, with the government capitalising on its expertise in biotechnology, computing hardware and producing infrastructures for supporting bioinformatics projects. Turning PM into an opportunity for citizens and patients requires the engagement of stakeholders internationally to define common research and development approaches, standards and priorities. In order to respond to these challenges, the EU supports actions developed within the International Consortium for Personalised Medicine (ICPerMed). The EU-funded IC2PerMed project will provide key solutions for enabling the convergence under ICPerMed of European and Chinese stakeholders towards a common approach of PM, involving policymakers and healthcare beneficiaries.
Fields of science
Programme(s)
Funding Scheme
CSA - Coordination and support actionCoordinator
20123 Milano
Italy
See on map
Participants (9)
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
00168 Roma
See on map
00185 Roma
See on map
70176 Stuttgart
See on map
8010 Graz
See on map
1202 Geneva
See on map
06560 Sophia Antipolis Valbonne
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
518083 Shenzhen
See on map
100021 Beijing
See on map
100084 Beijing
See on map